CRP and androgen insensitivity syndrome: Meta-analysis results showed that compared to the control group, patients in the experimental group had significantly reduced levels of CRP and TNF-α, indicating that the combination of GMI and Butylphthalide can significantly alleviate the inflammatory response in AIS patients, which is consistent with previous research conclusions.